Drug-Target Association Kinetics in Drug Discovery

被引:48
|
作者
IJzerman, Adriaan P. [1 ]
Guo, Dong [2 ]
机构
[1] Leiden Univ, LACDR, Div Drug Discovery & Safety, POB 9502, NL-2300 RA Leiden, Netherlands
[2] Xuzhou Med Univ, Jiangsu Key Lab New Drug Res & Clin Pharm, 209 Tongshan Rd, Xuzhou 221004, Jiangsu, Peoples R China
基金
中国国家自然科学基金;
关键词
PROTEIN-COUPLED RECEPTOR; BINDING-KINETICS; RESIDENCE TIME; IN-VIVO; LIGAND-BINDING; LONG; DISSOCIATION; MECHANISM; EFFICACY; PHARMACOLOGY;
D O I
10.1016/j.tibs.2019.04.004
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The important role of ligand-receptor binding kinetics in drug design and discovery is increasingly recognized by the drug research community. Over the past decade, accumulating evidence has shown that optimizing the ligand's dissociation rate constant can lead to desirable duration of in vivo target occupancy and, hence, improved pharmacodynamic properties. However, the association rate constant as a pharmacological principle remains less investigated, whereas it can play an equally important role in the selection of drug candidates. This review provides a compilation and discussion of otherwise scarce and dispersed information on this topic, bringing to light the importance of drug -target association in kinetics-directed drug design and discovery.
引用
收藏
页码:861 / 871
页数:11
相关论文
共 50 条
  • [1] Drug-Target Kinetics in Drug Discovery
    Tonge, Peter J.
    ACS CHEMICAL NEUROSCIENCE, 2018, 9 (01): : 29 - 39
  • [2] Drug-target interaction kinetics: underutilized in drug optimization?
    Copeland, Robert A.
    FUTURE MEDICINAL CHEMISTRY, 2016, 8 (18) : 2173 - 2175
  • [3] Non-specificity of drug-target ineractions: Consequences for drug discovery
    Maggiora, Gerald
    Gokhale, Vijay
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2015, 250
  • [4] Non-Specificity of Drug-Target Interactions - Consequences for Drug Discovery
    Maggiora, Gerald
    Gokhale, Vijay
    FRONTIERS IN MOLECULAR DESIGN AND CHEMIAL INFORMATION SCIENCE - HERMAN SKOLNIK AWARD SYMPOSIUM 2015: JURGEN BAJORATH, 2016, 1222 : 91 - 142
  • [5] Understanding the influence of drug-target binding kinetics on in vivo drug effects
    de lange, Elizabeth
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2017, 254
  • [6] Affinity-Based Methods in Drug-Target Discovery
    Rylova, Gabriela
    Ozdian, Tomas
    Varanasi, Lakshman
    Soural, Miroslav
    Hlavac, Jan
    Holub, Dusan
    Dzubak, Petr
    Hajduch, Marian
    CURRENT DRUG TARGETS, 2015, 16 (01) : 60 - 76
  • [7] Applications of drug-target data in translating genomic variation into drug discovery opportunities
    Gaulton, Anna
    ABSTRACTS OF PAPERS OF THE AMERICAN CHEMICAL SOCIETY, 2016, 251
  • [8] Advances and Challenges in Milestoning Simulations for Drug-Target Kinetics
    Ojha, Anupam Anand
    Votapka, Lane W.
    Amaro, Rommie E.
    JOURNAL OF CHEMICAL THEORY AND COMPUTATION, 2024, 20 (22) : 9759 - 9769
  • [9] Thermodynamics and Kinetics of Drug-Target Binding by Molecular Simulation
    Decherchi, Sergio
    Cavalli, Andrea
    CHEMICAL REVIEWS, 2020, 120 (23) : 12788 - 12833
  • [10] Drug-Target Networks
    Vogt, Ingo
    Mestres, Jordi
    MOLECULAR INFORMATICS, 2010, 29 (1-2) : 10 - 14